Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints

Audrey Lequeux, Muhammad Zaeem Noman, Malina Xiao, Delphine Sauvage, Kris Van Moer, Elodie Viry, Irene Bocci, Meriem Hasmim, Manon Bosseler, Guy Berchem, Bassam Janji*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

81 Citations (Scopus)


Compared to traditional therapies, such as surgery, radio-chemotherapy, or targeted approaches, immunotherapies based on immune checkpoint blockers (ICBs)have revolutionized the treatment of cancer. Although ICBs have yielded long-lasting results and have improved patient survival, this success has been seriously challenged by clinical observations showing that only a small fraction of patients benefit from this revolutionary therapy and no benefit has been found in patients with highly aggressive tumors. Efforts are currently ongoing to identify factors that predict the response to ICB. Among the different predictive markers established so far, the expression levels of immune checkpoint genes have proven to be important biomarkers for informing treatment choices. Therefore, understanding the mechanisms involved in the regulation of immune checkpoints is a key element that will facilitate novel combination approaches and optimize patient outcome. In this review, we discuss the impact of hypoxia and tumor cell plasticity on immune checkpoint gene expression and provide insight into the therapeutic value of the EMT signature and the rationale for novel combination approaches to improve ICB therapy and maximize the benefits for patients with cancer.

Original languageEnglish
Pages (from-to)13-20
Number of pages8
JournalCancer Letters
Publication statusPublished - 28 Aug 2019


  • Cancer immunotherapy
  • Epithelial-to-mesenchymal transition
  • HIF
  • Immune checkpoint blockers
  • Immune suppression
  • PD-L1 and CD47


Dive into the research topics of 'Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints'. Together they form a unique fingerprint.

Cite this